Arena Pharmaceuticals Inc (NASDAQ:ARNA)

51.22
Delayed Data
As of Sep 13
 -1.36 / -2.59%
Today’s Change
31.97
Today|||52-Week Range
64.48
+31.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues3.6M8.6M801.1M1.0M
 
 
 
 
 
Depreciation And Amortization961.0K896.0K764.0K791.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses38.6M52.4M61.2M68.8M
 
 
 
 
 
Research And Development28.8M37.9M45.4M51.2M
 
 
 
 
 
Total Operating Expenses39.6M53.3M62.0M69.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.0M-44.6M739.1M-68.6M
 
 
 
 
 
Extraordinary Charge0.000.00-14.6M0.00
 
 
Interest Expense On Debt1.4M1.4M1.2M1.2M
 
 
 
 
 
Other Expenses589.0K1.5M711.0K780.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-34.3M-41.6M730.5M-61.4M
 
 
 
 
 
Income Taxes0.00-110.3M-110.3M0.00
 
 
 
Net Income-34.3M68.7M620.1M-61.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.4M49.4M49.5M49.7M
 
 
 
 
 
Shares To Calculate EPS Diluted49.4M50.8M51.3M49.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.70$1.35$12.10-$1.24
 
 
 
 
 
EPS Diluted-$0.70$1.35$12.10-$1.24